MedPath

Clinical trial on Covid patients with mild to moderate symptoms

Phase 2
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2022/01/039852
Lead Sponsor
Zum Heilen Diagnostic Therapeutics ZH DT
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects aged 18-65 years of age and of either sex

2.Subjects who are willing to give consent to the study

3.COVID-19 positive clinical symptoms and (subsequently) confirmed by the current recommended confirmatory test (RT-PCR).

4.Mild to Moderate disease (NEWS score Less than/equal to 8)

5.Can take oral medicines

6.Subject willing to abide by and comply with the study protocol

Exclusion Criteria

1.Age less than 18 years and more than 65 years

2.Pregnancy and lactation

3.Severe or complicated course of COVID-19 disease

4.Presence of acute hypoxic respiratory failure/ need for Intensive care unit (ICU) stay/ Patients who need mechanical ventilation.

5.Any uncontrolled systemic disease, infection

6.Those with serious Cardiovascular, Cerebrovascular, Respiratory, Liver or Renal disease or any other disorder.

7.Other conditions, which in the opinion of the investigators makes the patient unsuitable for enrolment or could interfere in adherence to of the study protocol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath